Cognitive behavioral therapy for insomnia comorbid with COPD is feasible with preliminary evidence of positive sleep and fatigue effects
Mary C Kapella1, James J Herdegen2, Michael L Perlis3, Joan L Shaver4, Janet L Larson5, Julie A Law2, David W Carley1
1Center for Narcolepsy, Sleep and Health Research, Department of Biobehavioral Science, College of Nursing, 2Section of Pulmonary, Critical Care, Sleep and Allergy, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA; 3Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA; 4College of Nursing, University of Arizona, Tucson, AZ, USA; 5Division of Acute, Critical and Long Term Care Programs, University of Michigan School of Nursing, Ann Arbor, MI, USA
Background: Many people with COPD report difficulties falling asleep or staying asleep, insufficient sleep duration, or nonrestorative sleep. Cognitive behavioral therapy for insomnia (CBT-I) has proved effective not only in people with primary insomnia but also in people with insomnia comorbid with psychiatric and medical illness (eg, depression, cancer, and chronic pain). However, CBT-I has rarely been tested in those with COPD who have disease-related features that interfere with sleep and may lessen the effectiveness of such therapies. The purpose of this study was to determine the feasibility of applying a CBT-I intervention for people with COPD and to assess the impact of CBT-I on insomnia severity and sleep-related outcomes, fatigue, mood, and daytime functioning.
Methods: The study had two phases. In Phase 1, a 6-weekly session CBT-I intervention protocol in participants with COPD was assessed to examine feasibility and acceptability. Phase 2 was a small trial utilizing a prospective two-group pre- and post-test design with random assignment to the six-session CBT-I or a six-session wellness education (WE) program to determine the effects of each intervention, with both interventions being provided by a nurse behavioral sleep medicine specialist.
Results: Fourteen participants (five in Phase 1 and nine in Phase 2) completed six sessions of CBT-I and nine participants completed six sessions of WE. Participants indicated that both interventions were acceptable. Significant positive treatment-related effects of the CBT-I intervention were noted for insomnia severity (P = 0.000), global sleep quality (P = 0.002), wake after sleep onset (P = 0.03), sleep efficiency (P = 0.02), fatigue (P = 0.005), and beliefs and attitudes about sleep (P = 0.000). Significant positive effects were noted for depressed mood after WE (P = 0.005).
Conclusion: Results suggest that using CBT-I in COPD is feasible and the outcomes compare favorably with those obtained in older adults with insomnia in the context of other chronic illnesses.
Keywords: CBT-I, emphysema, chronic bronchitis, sleep disturbance
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]
Readers of this article also read:
Nanostructured lipid carrier surface modified with Eudragit RS 100 and its potential ophthalmic functions
Zhang W, Li X, Ye T, Chen F, Yu S, Chen J, Yang X, Yang N, Zhang J, Liu J, Pan W, Kong J
Published Date: 11 September 2014
COPD exacerbations admitted to intensive care unit. Organization, mortality, and noninvasive or invasive mechanical ventilation strategies: are they sufficiently well known?
Published Date: 29 July 2013
Murphy DE, Panos RJ
Published Date: 18 April 2013
A pilot study of the impact of high-frequency chest wall oscillation in chronic obstructive pulmonary disease patients with mucus hypersecretion
Chakravorty I, Chahal K, Austin G
Published Date: 14 December 2011
Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims
Mapel DW, Dalal AA, Blanchette CM, Petersen H, Ferguson GT
Published Date: 9 November 2011
Factors associated with good self-rated health and quality of life in subjects with self-reported COPD
Arne M, Lundin F, Boman G, Janson C, Janson S, Emtner M
Published Date: 7 October 2011
Disability related to COPD tool (DIRECT): towards an assessment of COPD-related disability in routine practice
Aguilaniu B, Gonzalez-Bermejo J, Regnault A, Dias Barbosa C, Arnould B, Mueser M, Granet G, Bonnefoy M, Similowski T
Published Date: 5 July 2011
Seemungal TA, Lun JC, Davis G, Neblett C, Chinyepi N, Dookhan C, Drakes S, Mandeville E, Nana F, Setlhake S, King CP, Pinto Pereira L, Delisle J, Wilkinson TM, Wedzicha JA
Published Date: 4 July 2011
Comparison of efficacy of long-acting bronchodilators in emphysema dominant and emphysema nondominant chronic obstructive pulmonary disease
Fujimoto K, Kitaguchi Y, Kanda S, Urushihata K, Hanaoka M, Kubo K
Published Date: 1 April 2011
Sabina Antonela Antoniu
Published Date: 17 February 2011